Small Animal Imaging Market Synopsis:<\/p>\n
Small Animal Imaging Market Size Was Valued at USD 1.19 Billion in 2023, and is Projected to Reach USD 2.16 Billion by 2032, Growing at a CAGR of 6.87% From 2024-2032.<\/p>\n
The small animal imaging is defined here as the application of modern imaging techniques for visualizing and characterizing small animals, predominantly rodents. Such techniques include, MRI, PET, CT, US, optical imaging and SPECT. These technologies, therefore, enable non-invasive tracking of physiological, anatomical, and molecular changes in small animals making them valuable in drug development, modelling diseases, and developing targeted treatment. The market is influenced by the increasing requirement for high throughput imaging solutions to accelerate research, particularly in cancer, neuroscience, cardiovascular, and immunological research.<\/p>\n
The global non-human small animal imaging market has been growing steadily for a while because of using less invasive imaging methods in experiments. As various imaging capabilities are developed, the researchers get better data and increased precision in finding the best medical products faster. The demand for small animal imaging investments comes from the pharmaceutical and biotechnology industries in which these imaging tools are applied for the assessment of drug effectiveness, development of disease models, and as well as toxicity studies. Moreover, the expansion of multimodal imaging solutions that integrate PET and other imaging technology like PET\/CT and PET\/MRI is projected to drive the market higher due to the better imaging facilities and improved understanding of the biological process of the disease.<\/p>\n
With an increasing emphasis on individualised treatment of patients and disease, the role of small animal imaging is becoming more important in elucidating disease pathophysiology and evaluating treatment outcomes. The increasing use of less invasive methods to study the animal models other than euthanasia is also fuelling the market growth.<\/p>\n
Small Animal Imaging Market Trend Analysis:<\/p>\n
Advancements in Hybrid Imaging Systems<\/p>\n
The small animal imaging market has been growing at a steady rate over the years because of the continually growing usage of non-invasive imaging in a preclinical research setting. As technology in imaging improves, researchers are therefore able to get much more accurate data thus improving efficiency in the drug development processes. Another field that has high demand of small animal imaging is pharmacological and biotechnological research where these imaging techniques are applied to drug evaluation, disease modelling and toxicity review. In addition, the expansion of more advanced imaging technologies, like PET\/CT and PET\/ MRI, is also expected to directly advance the market because of the significantly improved imaging quality and better understanding of disease processes.<\/p>\n
Small animal imaging has become increasingly important as the need for targeting individuals medicine is continuously on an increase, in elucidating disease processes and evaluating the potentials of therapeutic procedures. The markets progress is also benefited by the growing tendency towards less invasive investigative procedures, meaning that scientists do not have to sacrifice animal models, in order to measure and observe their behaviour. <\/p>\n
Increasing Use of Imaging in Oncology Research<\/p>\n
Cancer research extensively employs small animals like rodents where preclinical test of new treatments and therapies is carried out. Imaging techniques afford the researchers opportunity to observe the growth of the tumour, evaluate the effectiveness of the antitumor treatments, and observe possible toxic effects of the treatments on the animals without having to kill the animal. However, remaining a key hall mark of Huntington\u2019s disease, this ability to sp e model and observe real-time changes in tumour behaviours and responses to treatment could not be underestimated as critical to progressing our understanding and treatment portfolios for cancer.<\/p>\n
Cancer is a life-threatening disease that is on the rise globally and in this regard the need for diagnostic and treatment- monitoring imaging increases the market potential of small animal imaging. Besides, the increasing preferential pharmacotherapies, immunotherapies and precision medicine compounded by cancer complex nature fuels the demand for advanced imaging solutions for the oncology drug development and clinical trials. Small animal imaging technologies play a central role in assessing the safety and efficacy of these innovative treatments and any firm that is able to provide high performance imaging systems that are appropriate to oncology applications will be well set for growth. It is believed that this trend will continue to fuel a need for higher resolution imaging systems and definitely solidify the notion that small animal imaging is critical to cancer research.<\/p>\n
Small Animal Imaging Market Segment Analysis:<\/p>\n
Small Animal Imaging Market is Segmented on the basis of technology, application, end user and region<\/p>\n
By Technology, MRI (Magnetic Resonance Imaging) segment is expected to dominate the market during the forecast period<\/p>\n
By technology, the MRI (Magnetic Resonance Imaging) segment is expected to dominate the small animal imaging market during the forecast period. MRI remains a preferred choice for generating high-resolution anatomical images of the nervous and cardiovascular systems, making it essential in preclinical research. <\/p>\n
While other imaging techniques like PET\/CT, fluorescence, and ultrasound offer unique benefits in functional imaging and real-time assessments, MRI\u2019s ability to deliver detailed anatomical insights positions it as a critical tool in preclinical studies. The growing demand for advanced imaging to support research in oncology, neurology, and immunology further strengthens MRI\u2019s market leadership.<\/p>\n
By Application, cancer research segment expected to held the largest share <\/p>\n
By application, the cancer research segment will have the highest share in the small animal imaging industry. Small animal imaging is essential for assessing drug efficacy and safety of emerging drug candidates through the tracking of real-time therapeutic effect. It is especially important in cancer research for tumor growth evaluation, therapy outcome, and molecular pathway understanding of different types of cancers to direct drug development. <\/p>\n
Moreover, small animal imaging is also employed in cardiovascular research, neurological studies, and inflammation research. Increased usage of advanced imaging modalities in these applications is driving the growth of the market, enabling accurate drug testing and therapeutic assessment.<\/p>\n
Small Animal Imaging Market Regional Insights: <\/p>\n
North America is Expected to Dominate the Market Over the Forecast period <\/p>\n
North America emerged as the market leader in the small animal imaging market and contributed a significantly large market share. Much of this can be attributed to a stronger and more equipped healthcare system, heavy investment in life sciences and a greater density in the number of pharmaceutical organisations and academic institutions. Small animal imaging systems have a particularly large market in the United States, and this region continues to lead the demand for systems of this type across the world. The region\u2019s main driver is the biopharmaceutical industry with a large number of research institutes and universities as well as CROs using small animal imaging for disease modelling, compound testing and preclinical research. The prudent ecosystem of innovation and research promotes the uptake as well as growth of the enhanced imaging systems.<\/p>\n
The need shall drive more recognition of small animal imaging importance and entrench North America as the leading market for the niche services given ever increasingly demands for high precision and quality data in biomedical sciences. Other factors which specially favours this region include the sound regulation in the region, and the growing trend in the field of personalized medicine which also makes this region to lead in small animal imaging.<\/p>\n
Active Key Players in the Small Animal Imaging Market: <\/p>\n
Bruker Corporation (USA)<\/p>\n
Carestream Health (USA)<\/p>\n
Codex DNA (USA)<\/p>\n
FUJIFILM Holdings Corporation (Japan)<\/p>\n
GE Healthcare (USA)<\/p>\n
Halo Medical Technologies, Inc. (USA)<\/p>\n
Histoindex Pte Ltd (Singapore)<\/p>\n
Imalytics (Germany)<\/p>\n
Mediso Ltd. (Hungary)<\/p>\n
Miltenyi Biotec (Germany)<\/p>\n
MR Solutions Ltd. (UK)<\/p>\n
PerkinElmer, Inc. (USA)<\/p>\n
Other Active Players<\/p>\n","protected":false},"excerpt":{"rendered":"
Small Animal Imaging Market Size Was Valued at USD 1.19 Billion in 2023, and is Projected to Reach USD 2.16 Billion by 2032, Growing at a CAGR of 6.87% From 2024-2032.<\/p>\n","protected":false},"featured_media":6732,"template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[194],"product_tag":[],"class_list":["post-9830","product","type-product","status-publish","has-post-thumbnail","product_cat-healthcare-life-sciences","first","instock","virtual","purchasable","product-type-simple"],"acf":[],"yoast_head":"\n